Aliases & Classifications for Sexual Disorder

MalaCards integrated aliases for Sexual Disorder:

Name: Sexual Disorder 12 14
Sexual Dysfunction 69

Classifications:



External Ids:

Disease Ontology 12 DOID:0060043
UMLS 69 C0549622

Summaries for Sexual Disorder

Disease Ontology : 12 A disease of mental health that involves the impairment in normal sexual functioning.

MalaCards based summary : Sexual Disorder, also known as sexual dysfunction, is related to gynecomastia and prinzmetal's variant angina, and has symptoms including increased libido An important gene associated with Sexual Disorder is PDE5A (Phosphodiesterase 5A), and among its related pathways/superpathways are Vascular smooth muscle contraction and Platelet homeostasis. The drugs Fenofibrate and Angiotensin II have been mentioned in the context of this disorder. Affiliated tissues include prostate, spinal cord and bone, and related phenotypes are nervous system and cardiovascular system

Wikipedia : 72 Sexual dysfunction (or sexual malfunction or sexual disorder) is difficulty experienced by an individual... more...

Related Diseases for Sexual Disorder

Diseases related to Sexual Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 48)
# Related Disease Score Top Affiliating Genes
1 gynecomastia 29.7 KLK3 PRL SHBG
2 prinzmetal's variant angina 10.4 EDN1 NOS3
3 hypoactive sexual desire disorder 10.4 HTR1A SHBG
4 jejunoileitis 10.4 ALDH7A1 NOS1 NOS3
5 psychosexual disorder 10.3 HTR1A PDE5A SHBG
6 tetrahydrobiopterin deficiency 10.3 NOS1 NOS3 PRL
7 prostatic adenoma 10.3 KLK3 PRL SHBG
8 persistent fetal circulation syndrome 10.3 EDN1 NOS3 PDE5A
9 androgenic alopecia 10.3 KLK3 PRL SHBG
10 acute chest syndrome 10.3 EDN1 NOS1 NOS3
11 varicocele 10.3 NOS3 PRL SHBG
12 arteritic anterior ischemic optic neuropathy 10.3 ACE NOS3 PDE5A
13 hypertension, diastolic 10.3 ACE KCNMA1
14 renal artery disease 10.3 ACE NOS3
15 breast disease 10.3 KLK3 PRL SHBG
16 aortic coarctation 10.2 ACE EDN1 NOS3
17 coronary artery vasospasm 10.2 EDN1 NOS3
18 renovascular hypertension 10.2 ACE EDN1 NOS3
19 acute mountain sickness 10.2 ACE EDN1 NOS3
20 limb ischemia 10.2 ACE EDN1 NOS3
21 pulmonary edema 10.1 ACE EDN1 NOS3
22 sleep apnea 10.1 ACE EDN1 NOS3
23 arteries, anomalies of 10.1 ACE EDN1 NOS3
24 urinary system disease 10.1 ACE EDN1 KLK3
25 psychotic disorder 10.1 HTR1A NOS1 PRL
26 ischemic optic neuropathy 10.1 ACE EDN1 NOS3 PDE5A
27 acquired metabolic disease 10.1 ACE NOS3 PRL SHBG
28 nonarteritic anterior ischemic optic neuropathy 10.1 ACE EDN1 NOS3 PDE5A
29 atherosclerosis susceptibility 10.0 ACE EDN1 NOS3
30 respiratory failure 10.0 ACE EDN1 PDE4A
31 postmenopausal atrophic vaginitis 10.0 OXT SHBG
32 retinitis pigmentosa 19 10.0 ALDH7A1 KCNMA1
33 vasculogenic impotence 9.9 ACE ALDH7A1 NOS3 PDE4A PDE5A
34 pedophilia 9.9 OXT PRL
35 premenstrual tension 9.9 OXT PRL SHBG
36 female reproductive system disease 9.8 OXT PRL SHBG
37 autosomal dominant polycystic kidney disease 9.8 ACE EDN1 NOS3
38 disease of mental health 9.8 HTR1A OXT PDE5A
39 reproductive system disease 9.7 KLK3 OXT PRL SHBG
40 obsessive-compulsive disorder 9.6 HTR1A OXT PRL
41 prostatic hypertrophy 9.5
42 social phobia 9.5
43 infant gynecomastia 9.5
44 fetishism 9.5
45 premature ejaculation 9.5
46 prostatitis 9.5
47 pulmonary hypertension 9.4 ACE EDN1 NOS3 PDE4A PDE5A RHOA
48 impotence 9.1 ALDH7A1 EDN1 KCNMA1 KLK3 NOS1 NOS3

Graphical network of the top 20 diseases related to Sexual Disorder:



Diseases related to Sexual Disorder

Symptoms & Phenotypes for Sexual Disorder

UMLS symptoms related to Sexual Disorder:


increased libido

MGI Mouse Phenotypes related to Sexual Disorder:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.93 EDN1 HTR1A KCNMA1 NOS1 NOS3 OXT
2 cardiovascular system MP:0005385 9.91 ACE EDN1 HTR1A KCNMA1 NOS1 NOS3
3 normal MP:0002873 9.56 ALDH7A1 EDN1 NOS1 NOS3 PRKG1 RHOA
4 renal/urinary system MP:0005367 9.17 ACE EDN1 KCNMA1 NOS1 NOS3 OXT

Drugs & Therapeutics for Sexual Disorder

Drugs for Sexual Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 469)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fenofibrate Approved Phase 4 49562-28-9 3339
2
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
3
Felodipine Approved, Investigational Phase 4 72509-76-3 3333
4
Irbesartan Approved, Investigational Phase 4 138402-11-6 3749
5
Metoprolol Approved, Investigational Phase 4 51384-51-1, 37350-58-6 4171
6
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
7
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-61-6, 62-31-7 681
8
Risperidone Approved, Investigational Phase 4,Phase 3 106266-06-2 5073
9
Methyltestosterone Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-18-4 6010
10
Testosterone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-22-0 6013
11
Nebivolol Approved, Investigational Phase 4 152520-56-4, 118457-14-0, 99200-09-6 71301
12
Tadalafil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 171596-29-5 110635
13
Bupivacaine Approved, Investigational Phase 4,Phase 1 38396-39-3, 2180-92-9 2474
14
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
15
Drospirenone Approved Phase 4 67392-87-4 68873
16
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-28-2 5757
17
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 1 57-63-6 5991
18
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2 1994-09-7, 94-09-7 2337
19
Alfuzosin Approved, Investigational Phase 4,Phase 3 81403-80-7 2092
20
Tamoxifen Approved Phase 4,Phase 2 10540-29-1 2733526
21
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-84-3 187
22
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 137-58-6 3676
23
Alprostadil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 745-65-3 149351
24
Ropinirole Approved, Investigational Phase 4 91374-20-8, 91374-21-9 5095 497540
25
Tiagabine Approved, Investigational Phase 4 115103-54-3 60648
26
Zinc Approved, Investigational Phase 4 7440-66-6 32051 23994
27
Udenafil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 268203-93-6 6918523
28
Bupropion Approved Phase 4,Phase 2,Phase 3,Phase 1 34911-55-2, 34841-39-9 444
29
Norepinephrine Approved Phase 4,Phase 3,Phase 1 51-41-2 439260
30
Paroxetine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61869-08-7 43815
31
Vortioxetine Approved, Investigational Phase 4,Phase 3 508233-74-7 9966051
32
Curcumin Approved, Investigational Phase 4 458-37-7 969516
33
Yohimbine Approved, Investigational, Vet_approved Phase 4,Phase 1 146-48-5 8969
34
Nitric Oxide Approved Phase 4 10102-43-9 145068
35
Tacrolimus Approved, Investigational Phase 4,Phase 2 104987-11-3 445643 439492
36
Menthol Approved Phase 4 2216-51-5 16666
37
Loperamide Approved Phase 4,Early Phase 1 53179-11-6 3955
38
Mineral oil Approved, Vet_approved Phase 4 8042-47-5
39
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
40
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
41
Tibolone Approved, Investigational Phase 4,Phase 3 5630-53-5
42
Cyproterone Acetate Approved, Investigational Phase 4 427-51-0
43 Lynestrenol Approved, Investigational Phase 4 52-76-6
44
Estrone Approved Phase 4,Phase 1 53-16-7 5870
45
Sertraline Approved Phase 4,Phase 2 79617-96-2 68617
46
Medroxyprogesterone acetate Approved, Investigational Phase 4,Phase 3 71-58-9
47
Progesterone Approved, Vet_approved Phase 4,Phase 3 57-83-0 5994
48
Selegiline Approved, Investigational, Vet_approved Phase 4 14611-51-9 5195 26757
49
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 77-92-9 311
50 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 815)

# Name Status NCT ID Phase Drugs
1 Treatment of Hyperlipidemia and Sexual Dysfunction Unknown status NCT00923676 Phase 4 fenofibrate;Rosuvastatin;fenofibrate + rosuvastatin
2 Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions Unknown status NCT01021267 Phase 4 Saw palmetto berry extract
3 Combined Antihypertensive Therapy and Sexual Dysfunction Unknown status NCT01238705 Phase 4 Felodipine add Irbesartan;Felodipine add Metoprolol
4 A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders Unknown status NCT01742390 Phase 4 Aripiprazole;risperidone or paliperidone
5 Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning Males Unknown status NCT00313898 Phase 4 sildenafil (viagra)
6 Functional Outcome After Groin Hernia Mesh Repair: Open Versus Laparoscopy Unknown status NCT00625534 Phase 4
7 Testosterone Patch's Effects on the Cardiovascular System and Libido Unknown status NCT01208038 Phase 4 Intrinsa Transdermal testosterone patch
8 Nebivolol Effects on Endothelial Function and Erectile Function Unknown status NCT01885988 Phase 4 Nebivolol;Sugar Pill
9 Evaluation of Safety and Effectiveness of 2 Lower Dose Combined PDE5i's Versus Single Maximal Dose PDE5i Treatment Unknown status NCT01364701 Phase 4 Sildenafil 100 mg;Tadalafil 20 mg;Combination half of maximal dose for sildenafil & tadalafil
10 Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate Unknown status NCT00555087 Phase 4 Testosterone Undecanoate and/or PDE-5
11 Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Unknown status NCT00498680 Phase 4 Sildenafil, Vardenafil;Sildenafil;Vardenafil;Sildenafil & Vardenafil
12 Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain Unknown status NCT02022722 Phase 4 Trigger Point Injections Triamcinolone Acetonide, Bupivacaine Hydrochloride
13 Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis Unknown status NCT02344823 Phase 4 Vardenafil;Placebo intake once daily
14 Continuous Versus Cyclic Oral Contraceptives for Endometriosis Unknown status NCT02237131 Phase 4 Oral contraceptives cyclic;Oral contraceptives continuous
15 Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer Unknown status NCT00906269 Phase 4 Sildenafil therapy plus post-NSRRP HBO2T;Sildenafil therapy plus sham post-NSRRP HBO2T
16 A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury Unknown status NCT00725790 Phase 4 Vardenafil;Placebo
17 Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo Completed NCT00334048 Phase 4 Ropinirole (Requip)
18 Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction Completed NCT00174850 Phase 4 Gaitril
19 Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women Completed NCT00375297 Phase 4 sildenafil
20 PRILIGY Usage Patterns in Selected Populations Completed NCT01273545 Phase 4 PRILIGY (dapoxetine hydrochloride)
21 Statin Lowering Testosterone and Sexual Function Completed NCT02612714 Phase 4 Rosuvastatin
22 An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride Completed NCT01021670 Phase 4 Dapoxetine hydrochloride
23 Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II Completed NCT00377793 Phase 4 Levitra (Vardenafil, BAY38-9456);Placebo
24 Daily Tadalafil on Body Fat and Lean Mass Completed NCT02554045 Phase 4 Tadalafil;Placebo
25 Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder Completed NCT01971099 Phase 4 tribulus terrestris
26 Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder Completed NCT01975649 Phase 4 Tribulus Terrestris
27 SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin Completed NCT00486785 Phase 4 Alfuzosin
28 Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients Completed NCT01468519 Phase 4 Insulin;Insulin
29 The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer Completed NCT01421940 Phase 4 Placebo drug;Udenafil
30 Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study Completed NCT02204826 Phase 4 Korean Red Ginseng (KRG)
31 Sexual Functioning Study With Antidepressants Completed NCT00316160 Phase 4 Bupropion Hydrochloride Extended-release;Extended-release Venlafaxine
32 Comparing Effects of Diet, With or Without Exercise, on Sexual, Urinary and Endothelial Function, Inflammatory Profile and Quality of Life in Obese Men Completed NCT01642576 Phase 4
33 Effects of Diet-induced Weight Loss in Obese Men Completed NCT01554865 Phase 4
34 Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men Completed NCT01554735 Phase 4
35 Wellbutrin XL Effects on SSRIs Induced Changes Completed NCT00456820 Phase 4 Wellbutrin XL
36 Effects of Tribulus Terrestris on Sexual Function in Post-menopausal Women Completed NCT01407445 Phase 4 Placebo;Tribulus terrestris
37 Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers Completed NCT02932904 Phase 4 Vortioxetine;Paroxetine;Placebo
38 Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV) Completed NCT02450188 Phase 4 Vardenafil
39 The Efficacy and Safety of New Herbal Formula (KBMSI-2) in the Treatment of Erectile Dysfunction Completed NCT02413099 Phase 4 KBMSI-2
40 A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction Completed NCT02224846 Phase 4 Tadalafil
41 Study Evaluating the Effects of Avanafil on Semen Parameters Completed NCT01768676 Phase 4 avanafil;Placebo
42 Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction Completed NCT01698684 Phase 4 Placebo;Avanafil 100 mg;Avanafil 200 mg
43 A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China Completed NCT01352507 Phase 4 Tadalafil;Sildenafil
44 LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers Completed NCT01207947 Phase 4 Vardenafil (Levitra, BAY38-9456)
45 Efficacy and Safety of Lodenafil Carbonate in the Treatment of Erectile Dysfunction in Patients With Diabetes. Completed NCT01180283 Phase 4 lodenafil carbonate
46 Satisfaction, Confidence and Naturalness in Men With Psychogenic Erectile Dysfunction (ED) Completed NCT01153204 Phase 4 Sildenafil citrate
47 A Study in Erectile Dysfunction Completed NCT01130532 Phase 4 Tadalafil;Placebo
48 A Study in Patients With Erectile Dysfunction Completed NCT01122264 Phase 4 Tadalafil;Sildenafil Citrate
49 A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil Completed NCT01108900 Phase 4 sildenafil
50 A Study of Tadalafil After Radical Prostatectomy Completed NCT01026818 Phase 4 Tadalafil;Placebo

Search NIH Clinical Center for Sexual Disorder

Genetic Tests for Sexual Disorder

Anatomical Context for Sexual Disorder

MalaCards organs/tissues related to Sexual Disorder:

38
Prostate, Spinal Cord, Bone, Brain, Testes, Liver, Bone Marrow

Publications for Sexual Disorder

Articles related to Sexual Disorder:

(show all 20)
# Title Authors Year
1
Technological change and sexual disorder. ( 27028747 )
2016
2
Hebephilia as a sexual disorder. ( 25723776 )
2015
3
Sexual disorder improvement: a target or a way in treatment of fibromyalgia. A case report and brief review. ( 19802653 )
2010
4
Drug treatment of paraphilic and nonparaphilic sexual disorders. ( 19243704 )
2009
5
Male sexuality and psychological trauma: soldiers and sexual disorder in World War I and Weimar Germany. ( 19260157 )
2008
6
Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders. ( 17724838 )
2007
7
Treatment of paraphilic sexual disorder: the use of topiramate in fetishism. ( 16687996 )
2006
8
Comorbidity between social phobia and premature ejaculation: study on 242 males affected by sexual disorders. ( 16418108 )
2006
9
[The significance of the androgen-estrogen ratios in the clinical picture of sexual disorders in men]. ( 10878975 )
2000
10
Female hypoactive sexual disorder: case studies of physiologic androgen replacement. ( 10407790 )
1999
11
SEIZURE RELATED SEXUAL DISORDER. ( 28775613 )
1999
12
Pharmacological era in the treatment of sexual disorder. ( 9611685 )
1998
13
Gynecomastia and sexual disorders after the administration of omeprazole. ( 7771409 )
1995
14
Neurotransmitter, opiodergic system, steroid-hormone interaction and involvement in the replacement therapy of sexual disorders. ( 1979499 )
1990
15
Interruption in the maintenance of compulsive sexual disorder: two case studies. ( 3219064 )
1988
16
Treatment of sexual disorder: a prophylaxis for major pathology? ( 3820157 )
1987
17
Dyspareunia; a symptom of sexual disorder in the female. ( 1043847 )
1976
18
A note on avoidance conditioning techniques in sexual disorder. ( 5853245 )
1965
19
SEXUAL DISORDER IN POSTTRAUMATIC AND POSTCONCUSSIONAL STATES. ( 14128413 )
1964
20
Sexual disorder in 'mepacrine psychoses'. ( 15412077 )
1950

Variations for Sexual Disorder

Expression for Sexual Disorder

Search GEO for disease gene expression data for Sexual Disorder.

Pathways for Sexual Disorder

GO Terms for Sexual Disorder

Cellular components related to Sexual Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 caveola GO:0005901 8.8 KCNMA1 NOS1 NOS3

Biological processes related to Sexual Disorder according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 regulation of blood pressure GO:0008217 9.58 ACE EDN1 NOS3
2 regulation of sodium ion transport GO:0002028 9.56 NOS1 NOS3
3 vasoconstriction GO:0042310 9.55 EDN1 HTR1A
4 regulation of blood vessel size GO:0050880 9.54 EDN1 NOS3
5 nitric oxide mediated signal transduction GO:0007263 9.52 NOS1 NOS3
6 positive regulation of renal sodium excretion GO:0035815 9.51 EDN1 OXT
7 nitric oxide biosynthetic process GO:0006809 9.49 NOS1 NOS3
8 negative regulation of calcium ion transport GO:0051926 9.48 NOS1 NOS3
9 positive regulation of guanylate cyclase activity GO:0031284 9.46 NOS1 NOS3
10 response to hypoxia GO:0001666 9.46 EDN1 KCNMA1 NOS1 RHOA
11 negative regulation of potassium ion transport GO:0043267 9.43 NOS1 NOS3
12 positive regulation of prostaglandin secretion GO:0032308 9.37 EDN1 OXT
13 arginine catabolic process GO:0006527 9.32 NOS1 NOS3
14 negative regulation of hydrolase activity GO:0051346 9.26 NOS1 NOS3
15 negative regulation of blood pressure GO:0045776 9.13 NOS1 NOS3 OXT
16 regulation of systemic arterial blood pressure by endothelin GO:0003100 8.8 EDN1 NOS3 RHOA

Molecular functions related to Sexual Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.61 EDN1 OXT PRL
2 cGMP binding GO:0030553 9.4 PDE5A PRKG1
3 FMN binding GO:0010181 9.37 NOS1 NOS3
4 arginine binding GO:0034618 9.32 NOS1 NOS3
5 cadmium ion binding GO:0046870 9.26 NOS1 NOS3
6 NADPH-hemoprotein reductase activity GO:0003958 9.16 NOS1 NOS3
7 tetrahydrobiopterin binding GO:0034617 8.96 NOS1 NOS3
8 nitric-oxide synthase activity GO:0004517 8.62 NOS1 NOS3
9 protein binding GO:0005515 10.36 ALDH7A1 EDN1 HTR1A KCNMA1 KLK3 NOS1

Sources for Sexual Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....